Compounds > losartan
Page last updated: 2024-10-30

losartan and Extranodal NK-T-Cell Lymphoma

losartan has been researched along with Extranodal NK-T-Cell Lymphoma in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, GH1
Miao, FA1
Xu, JG1
Zhang, Y1

Other Studies

1 other study available for losartan and Extranodal NK-T-Cell Lymphoma

ArticleYear
Angiotensin II enhances the proliferation of Natural Killer/T-cell lymphoma cells via activating PI3K/Akt signaling pathway.
    Bioscience reports, 2020, 10-30, Volume: 40, Issue:10

    Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy

2020